Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata

Summary

This study (Unique Protocol ID: ZGJAK020) as an extension of the ongoing "Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata (Unique Protocol ID:ZGJAK020)" study. After completion of ZGJAK018 study, the study will be directly extend with an "open-label design".

Timeline

Start

2022-03-25

Primary completion

2024-06-28

Completion

2024-06-28

Drugs

Indications